Advantage Alpha Capital Partners »

Protagonist Therapeutics shares owned by Advantage Alpha Capital Partners

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Advantage Alpha Capital Partners from 13F filings

Historical chart of Advantage Alpha Capital Partners investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Advantage Alpha Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Advantage Alpha Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $386k 5.8k 66.43
2025-06-30 $385k 7.0k 55.27
2025-03-31 $418k 8.6k 48.36
2024-12-31 $222k 5.7k 38.60
2024-09-30 $510k 11k 45.00